Commitments and Contingencies (Details) - USD ($) $ in Thousands |
1 Months Ended | 3 Months Ended | ||||||
---|---|---|---|---|---|---|---|---|
May 31, 2021 |
Apr. 30, 2020 |
Mar. 31, 2025 |
Mar. 31, 2024 |
Dec. 31, 2024 |
Oct. 06, 2022 |
Apr. 30, 2022 |
Oct. 31, 2021 |
|
Commitments and Contingencies [Line Items] | ||||||||
Issued shares (in Shares) | 7,589,965 | 3,138,804 | ||||||
Sales and marketing expense | $ 1,647 | $ 1,381 | ||||||
Termination agreement, description | In accordance with the Termination Agreement, (i) the Company paid the Representative $1,000 in cash; and (ii) the Company agreed to pay the Representative (a) $85 per month during the six months after the date of the Termination Agreement in return for efforts by the Representative to transition operations to the Company, (b) 20% of net sales of the product sold in the United States and Puerto Rico until December 31, 2023 and (c) after December 31, 2023, 10% of net sales until such time as the aggregate amount paid to the Representative under this clause (c) and clause (b) above equal $3,600. In the event of an acquisition of the Company, the Company will pay the Representative $3,600 less previous amounts paid pursuant to clause (b) and clause (c) above. The Company recorded a charge of $1,000 for the payment to the Representative in the fourth quarter of 2022 and expensed the $85 per month charges as incurred over the six-month period. For payments under clause (b) and clause (c) above, the Company originally estimated the fair value of the liability using level 3 hierarchy inputs based on a Monte Carlo simulation of future revenues with a 25% quarterly estimated standard deviation of growth rates and a 10% probability of dissolution, discounted at an estimated discount rate of 15.4%. Based on the Company’s fair value analysis, a total of $2,611 was charged to sales and marketing expense in the statements of operations and comprehensive loss and recorded as accrued commissions in the balance sheets. For subsequent periods, the Company has used a discounted cash flow model with an estimated discount rate of 15.4% to adjust the liability for actual payments made and updated projections of the timing of future payments. | |||||||
Sales Representative Agreement [Member] | ||||||||
Commitments and Contingencies [Line Items] | ||||||||
Agreement term | 5 years | |||||||
Agreement additional extension term | 5 years | |||||||
Cash paid | $ 500 | |||||||
Issued shares (in Shares) | 53,757 | 31,235 | 4,445 | |||||
Sales and marketing expense | $ 880 | |||||||
Fair value | $ 333 | |||||||
Bonus paid | 6,000 | |||||||
Restated Sales Agreement [Member] | ||||||||
Commitments and Contingencies [Line Items] | ||||||||
Equity ownership percent | 3.00% | |||||||
Termination Agreement [Member] | ||||||||
Commitments and Contingencies [Line Items] | ||||||||
Ultimately expects to expense | $ 3,600 |